Variable | Male n = 138 | Female n = 83 | p |
---|---|---|---|
Age | 37 (31–46) | 36 (33–44) | 0.95 |
Unmarried | 66 (48%) | 40 (48%) | 0.96 |
Unemployed | 19 (14%) | 34 (41%) | < 0.001 |
Living outside Yangon | 38 (28%) | 16 (19%) | 0.17 |
Did not complete high school | 93 (68%) | 60 (72%) | 0.54 |
Number of family members living at home | 3 (2–4) | 3 (2–5) | 0.90 |
Per-capita household income (USD) | 46.15 (30.76–76.92) | 51.28 (28.04–76.92) | 0.90 |
Hazardous alcohol consumption | 47/137 (34%) | 0/83 | < 0.0001 |
Current cigarette smoker | 54/128 (42%) | 2/83 (2%) | < 0.0001 |
Active injecting drug use | 3/138 (2%) | 0/83 | 0.29 |
Presently chewing betel nut | 70/118 (59%) | 7/82 (9%) | < 0.0001 |
Hepatitis B surface antigen positive | 15/127 (12%) | 6/79 (8%) | 0.48 |
Hepatitis C antibody positive | 4/127 (3%) | 2/79 (3%) | 1.0 |
Body mass index (kg/m2) | 19.3 (17.2–22.2) | 18.9 (16.1–22.3) | 0.29 |
Mean arm circumference (cm) | 25 (22–27) | 25 (22–27) | 0.99 |
WHO stage at enrolment | 1 (1–3) | 2 (1–3) | 0.02 |
CD4 cell count (cells/mm3) | 92 (41–157) | 92 (48–158) | 0.61 |
Receiving dolutegravir containing regimen | 117/137 (85%) | 64/82 (78%) | 0.16 |
Haemoglobin (g/dL) | 12 (10–13.2) | 10 (9–11) | 0.0001 |
Creatinine (µmol/L) | 95 (80–113) | 80 (70–100) | 0.0004 |
Dieda | 6/138 (4%) | 0/83 | 0.09 |
Hospitaliseda | 2/138 (1%) | 0/83 | 0.53 |
Died or hospitaliseda | 8/138 (6%) | 0/83 | 0.03 |
Lost to follow-upa | 10/138 (7%) | 6/83 (7%) | 1.0 |
Detectable virusa | 53/99 (54%) | 20/61 (33%) | 0.01 |